Selinexor is an anticancer drug that is indicated for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) in combination with dexamethasone. Selinexor is an anticancer drug used for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) in combination with dexamethasone. Refractory multiple myeloma is a cancer of white blood cells that is not managed by treatment.<\/p>\n
selinexor tablets is a cancer medicine used to treat multiple myeloma (a cancer of the bone marrow). It is used together with two other medicines, bortezomib and dexamethasone, in adults who have received at least one previous treatment. It is also used together with dexamethasone in adults who have received at least four previous treatments and whose disease has worsened since the last treatment.<\/p>\n
Nexpovio contains the\u00a0active substance<\/a>\u00a0selinexor.<\/p>\n To access selinexor tablets sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN’s Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj)<\/p>\n Xpovio (selinexor) is a medication used for the treatment of patients with\u00a0 relapsed\/refractory multiple myeloma or diffuse large B-cell lymphoma.\u00a0It has been approved by the European Medicines Agency (EMA) under the brand name Nexpovio (selinexor).<\/p>\n Facts about selinexor tablets<\/strong><\/p>\n Disease Indications-Lymphoma, Multiple Myeloma If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import “selinexor tablets\u201d based on the information you provide.<\/strong><\/p>\nHow can 1 go about obtaining selinexor tablets?<\/h3>\n
XPOVIO (selinexor) tablets, for oral use Initial U.S. Approval: 2019<\/h5>\n","protected":false},"excerpt":{"rendered":"
selinexor tablets,
\nfor oral use Initial U.S. Approval: 2019<\/h2>\n
\nManufacturer-Karyopharm
\nUsage-Oral
\nMedicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n